Close
Nordic 9Nordic 9

Principia SGR (investor - Venture Capital)

Italy principiasgr.it
See something wrong or missing? Let us know
Offices:Milan

Principia SGR is an Ital-based venture and growth capital company.

Average round investment:34.83M USD
Average number per year:2.0
Distribution: 2020 (2)
Portfolio companies: Italy Wise SrlFrance Enterome
Mostly invests in: Italy Italy (1) Manufacturing (1)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Principia SGR

Name Criteria
France Creadev
76%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Netherlands BioGeneration Ventures
76%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Switzerland Metellus AG
76%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Switzerland Roche Venture Fund
76%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Novartis Venture Fund
75%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Invus
75%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
France Andera Partners
74%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Luxembourg Vesalius Biocapital Partners
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Netherlands Merck Ventures
72%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 3.5
  • Active last 12 months: Yes
Spain Ysios Capital
72%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Biotech
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 2.0
Top